Parameter | HR | 95% CI | p-value |
---|---|---|---|
Gender, female vs. male | 0.940 | 0.460–1.910 | 0.867 |
Age, years (< 65 vs. ≥ 65) | 0.380 | 0.150–0.940 | 0.036* |
ECOG-PS, 0~1 vs. 2 | 1.920 | 0.710–5.210 | 0.202 |
Child-Pugh classification, B vs. C | 1.610 | 0.690–3.740 | 0.268 |
Comorbidity, yes vs. no | 0.950 | 0.360–2.490 | 0.912 |
Preoperative biliary drainage, yes vs. no | 2.810 | 1.130–6.950 | 0.026* |
CA-199, U/mL | 1.000 | 1.000–1.000 | 0.895 |
Radical resection, yes vs. no | 0.080 | 0.010–0.710 | 0.024* |
Operation time, min | 1.000 | 0.990–1.000 | 0.295 |
Hilar blockade, yes vs. no | 2.170 | 0.910–5.180 | 0.081 |
Tumor size, < 3 cm vs. ≥ 3 cm | 0.970 | 0.370–2.560 | 0.948 |
Surgical margin, R0/R1/R2 | 0.970 | 0.400–2.360 | 0.940 |
Bismuth type, I/II/IIIa/IIIb/IV | 1.380 | 0.740–2.570 | 0.309 |
Pathological differentiation types, highly/moderately/poorly | 0.770 | 0.410–1.440 | 0.409 |
Perineuronal invasion, yes vs. no | 1.450 | 0.590–3.580 | 0.423 |
Lymph node metastasis, yes vs. no | 2.140 | 0.990–4.630 | 0.053 |
Postoperative complications, yes vs. no | 1.740 | 0.570–5.330 | 0.330 |
Postoperative adjuvant therapy, yes vs. no | 0.380 | 0.150–0.960 | 0.040* |
Treatment (LS vs. OS) | 1.290 | 0.530–3.160 | 0.570 |